Coronary microvascular dysfunction: Considerations for diagnosis and treatment.

Cleve Clin J Med

Associate Director, Barbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA; Investigator, Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) NCT03417388; Investigator, Women's Ischemia Syndrome Evaluation (WISE) NCT00000554

Published: October 2021

Ischemia and no obstructive coronary artery disease (INOCA) is an increasingly recognized cause of angina, and it is more commonly diagnosed in women. Coronary microvascular dysfunction (CMD), or the abnormal dilation and constriction of the small vessels of the heart, is the underlying cause of INOCA in one-half of cases. This review discusses coronary microvascular pathophysiology, considerations for invasive coronary function testing and noninvasive diagnostic modalities, implications for management, and remaining knowledge gaps.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813544PMC
http://dx.doi.org/10.3949/ccjm.88a.20140DOI Listing

Publication Analysis

Top Keywords

coronary microvascular
12
microvascular dysfunction
8
coronary
5
dysfunction considerations
4
considerations diagnosis
4
diagnosis treatment
4
treatment ischemia
4
ischemia obstructive
4
obstructive coronary
4
coronary artery
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!